Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically predisposed individuals (HLA-DQ2/DQ8), with a global seroprevalence of approximately 1.4%. However, only one in four ...

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ever before. Researchers identified two previously unknown proteins in the ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

The pace of oncology innovation has accelerated beyond managed care's capacity to keep up, with gaps persisting across ...

Penn Medicine researchers will present advances in CAR T cell therapy, cancer interception, prevention, and more at the 2026 AACR Annual Meeting.

After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical data for its electric field-based treatment in metastatic cases of the ...

The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...

A revolutionary new study in mice could pave the way for curing type 1 diabetes by creating a blended immune system that ...

Metastatic kidney survival rates don’t predict individual outcomes. A number of factors, including overall health, tumor characteristics, and response to treatment, influence prognosis and survival.